BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20397072)

  • 1. Effects of varicella-zoster virus on cell cycle regulatory pathways.
    Moffat JF; Greenblatt RJ
    Curr Top Microbiol Immunol; 2010; 342():67-77. PubMed ID: 20397072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the JNK Pathway in Varicella-Zoster Virus Lytic Infection and Reactivation.
    Kurapati S; Sadaoka T; Rajbhandari L; Jagdish B; Shukla P; Ali MA; Kim YJ; Lee G; Cohen JI; Venkatesan A
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Human Skin Tissue Model To Study Varicella-Zoster Virus and Human Cytomegalovirus.
    Lloyd MG; Smith NA; Tighe M; Travis KL; Liu D; Upadhyaya PK; Kinchington PR; Chan GC; Moffat JF
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32878893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice.
    Rowe J; Greenblatt RJ; Liu D; Moffat JF
    Antiviral Res; 2010 Jun; 86(3):276-85. PubMed ID: 20307580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella-zoster virus infection of human foreskin fibroblast cells results in atypical cyclin expression and cyclin-dependent kinase activity.
    Leisenfelder SA; Moffat JF
    J Virol; 2006 Jun; 80(11):5577-87. PubMed ID: 16699039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts.
    Zerboni L; Reichelt M; Arvin A
    Curr Top Microbiol Immunol; 2010; 342():255-76. PubMed ID: 20225014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of host CD59 expression by varicella-zoster virus in human xenografts in vivo.
    Wang W; Wang X; Yang L; Fu W; Pan D; Liu J; Ye J; Zhao Q; Zhu H; Cheng T; Xia N
    Virology; 2016 Apr; 491():96-105. PubMed ID: 26891237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella-zoster virus infection of a human CD4-positive T-cell line.
    Zerboni L; Sommer M; Ware CF; Arvin AM
    Virology; 2000 May; 270(2):278-85. PubMed ID: 10792986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway.
    Zapata HJ; Nakatsugawa M; Moffat JF
    J Virol; 2007 Jan; 81(2):977-90. PubMed ID: 17079291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Bim enhances replication of varicella-zoster virus and delays plaque formation in virus-infected cells.
    Liu X; Cohen JI
    J Virol; 2014 Jan; 88(2):1381-8. PubMed ID: 24227856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simian varicella virus causes robust transcriptional changes in T cells that support viral replication.
    Arnold N; Messaoudi I
    Virus Res; 2017 Jun; 238():226-235. PubMed ID: 28698046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of varicella-zoster virus DNA and gene products in tissues of a first-trimester varicella-infected fetus.
    Nikkels AF; Delbecque K; Pierard GE; Wienkotter B; Schalasta G; Enders M
    J Infect Dis; 2005 Feb; 191(4):540-5. PubMed ID: 15655777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ORF61 protein of Varicella-zoster virus influences JNK/SAPK and p38/MAPK phosphorylation.
    Rahaus M; Desloges N; Wolff MH
    J Med Virol; 2005 Jul; 76(3):424-33. PubMed ID: 15902710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella-zoster virus ORF12 protein activates the phosphatidylinositol 3-kinase/Akt pathway to regulate cell cycle progression.
    Liu X; Cohen JI
    J Virol; 2013 Feb; 87(3):1842-8. PubMed ID: 23192871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice.
    Moffat JF; Stein MD; Kaneshima H; Arvin AM
    J Virol; 1995 Sep; 69(9):5236-42. PubMed ID: 7636965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis.
    Sen N; Che X; Rajamani J; Zerboni L; Sung P; Ptacek J; Arvin AM
    Proc Natl Acad Sci U S A; 2012 Jan; 109(2):600-5. PubMed ID: 22190485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and therapeutic aspects of varicella-zoster virus infection.
    Quinlivan M; Breuer J
    Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the function of tegument proteins from the varicella zoster virus.
    Wang W; Cheng T; Zhu H; Xia N
    Sci China Life Sci; 2015 Aug; 58(8):739-49. PubMed ID: 26208824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J; Whitley R
    Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella-zoster virus influences the activities of components and targets of the ERK signalling pathway.
    Rahaus M; Desloges N; Wolff MH
    J Gen Virol; 2006 Apr; 87(Pt 4):749-758. PubMed ID: 16528022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.